The New England journal of medicine
-
Multicenter Study Clinical Trial
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.
Cardiac pacemakers are limited by device-related complications, notably infection and problems related to pacemaker leads. We studied a miniaturized, fully self-contained leadless pacemaker that is nonsurgically implanted in the right ventricle with the use of a catheter. ⋯ The leadless cardiac pacemaker met prespecified pacing and sensing requirements in the large majority of patients. Device-related serious adverse events occurred in approximately 1 in 15 patients. (Funded by St. Jude Medical; LEADLESS II ClinicalTrials.gov number, NCT02030418.).
-
Editorial Comment
Heart Failure and Sleep-Disordered Breathing - The Plot Thickens.